Insys Therapeutics

^{Priced, Nasdaq: INSY}

Markets an opioid and synthetic marijuana drug for cancer pain and CINV.

Industry: Health Care

First Day Return: +18.8%

INSY

Markets an opioid and synthetic marijuana drug for cancer pain and CINV.

IPO News for Insys Therapeutics

US IPO Recap: Activity remains robust with five pricings, five setting terms and four new filers 05/06/13
Insys Therapeutics prices IPO at $8, at the low end of the revised range 05/02/13
Insys Therapeutics decreases range, now plans to raise $36 million 05/02/13

IPO Data
IPO Date	05/02/2013
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$32
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.insysrx.com
Headquarters	Phoenix, AZ, United States
Founded	1990
Employees at IPO	119

IPO News for Insys Therapeutics

Insys Therapeutics (INSY) Performance